Celiac Disease in Focus: Track 18 Highlights at WDLDC 2025 

The 16th World Digestive and Liver Diseases Conference (WDLDC 2025), happening on December 17–19, 2025, in Dubai, UAE, is set to bring together global experts in gastroenterology, hepatology, and digestive health. One of the most anticipated sessions, Track 18: Celiac Disease, will spotlight the latest research, diagnostics, and treatment strategies for this autoimmune condition that affects millions worldwide.

Understanding Celiac Disease: An Autoimmune Challenge

Celiac disease is triggered by the body’s immune reaction to gluten, leading to damage in the small intestine. At WDLDC 2025, experts will explore how genetics, environmental triggers, and immune system responses play a role in this lifelong condition.

Advances in Celiac Diagnosis

Early and accurate diagnosis is critical. This session will highlight biomarker research, non-invasive testing, and endoscopic advancements that are making celiac detection faster and more reliable than ever before.

Current and Emerging Treatment Options

While a strict gluten-free diet remains the cornerstone of celiac management, Track 18 will showcase cutting-edge therapies, enzyme supplements, and novel drug developments designed to support patients in achieving long-term gut health.

Future Directions in Celiac Research

From the role of the gut microbiome to innovative immune-modulating therapies, researchers are paving the way for a deeper understanding of celiac disease. Delegates will gain insights into promising studies that could redefine care in the near future.

📌 Submit your abstract: https://digestive-liverdiseases.utilitarianconferences.com/submit-abstract
📌 Register now: https://digestive-liverdiseases.utilitarianconferences.com/registration